Last update 26 Apr 2025

Denosumab Biosimilar(Outlook)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Denosumab Biosimilar (Outlook Therapeutics, Inc.), 地舒单抗生物类似药（Outlook Therapeutics, Inc.）, ONS-4010
Target
RANKL
Action
inhibitors
Mechanism
RANKL inhibitors(Tumor necrosis factor ligand superfamily member 11 inhibitors)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases+ [1]
Active Indication-
Inactive Indication
Bone metastasesGiant Cell Tumor of BoneOsteoporosis
Originator Organization
Outlook Therapeutics, Inc.Outlook Therapeutics, Inc.
Active Organization-
Inactive Organization
Outlook Therapeutics, Inc.Outlook Therapeutics, Inc.
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Related

100 Clinical Results associated with Denosumab Biosimilar(Outlook)
Login to view more data
100 Translational Medicine associated with Denosumab Biosimilar(Outlook)
Login to view more data
100 Patents (Medical) associated with Denosumab Biosimilar(Outlook)
Login to view more data
100 Deals associated with Denosumab Biosimilar(Outlook)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
M05BX04
-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bone metastasesPreclinical
United States
Outlook Therapeutics, Inc.Outlook Therapeutics, Inc.
04 May 2016
Giant Cell Tumor of BonePreclinical
United States
Outlook Therapeutics, Inc.Outlook Therapeutics, Inc.
04 May 2016
OsteoporosisPreclinical
United States
Outlook Therapeutics, Inc.Outlook Therapeutics, Inc.
04 May 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free